NCT00603343View on ClinicalTrials.gov

Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary Incontinence

PHASE3CompletedINTERVENTIONAL
Enrollment

303

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

September 30, 2006

Study Completion Date

December 31, 2006

Conditions
Overactive BladderUrinary IncontinenceChildren
Interventions
DRUG

Mictonetten 5 mg, coated tablet

propiverine 10 mg b.i.d. (17-27.9 kg BW) or propiverine 15 mg b.i.d. (28-45.0 kg BW)

DRUG

placebo

placebo corresponding to body weight

All Listed Sponsors
lead

APOGEPHA Arzneimittel GmbH

INDUSTRY

NCT00603343 - Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary Incontinence | Biotech Hunter | Biotech Hunter